Europe Dry Eye Syndrome Market Forecast by 2033

Market Size in 2024: USD 792.0 Billion
Market Forecast in 2033: USD 1,168.5 Billion
Market Growth Rate 2025-2033: 4.4%

The Europe dry eye syndrome market is set to rise from USD 792.0 billion in 2024 to USD 1,168.5 billion by 2033, registering a 4.4% CAGR. Ageing populations, higher screen exposure, and wider reimbursement of prescription therapies fuel growth.

Growth Drivers Fueling the European Dry Eye Syndrome Market

Ageing Demographics and Expanded Reimbursement

Europe’s median age is now 44 years, with Eurostat projecting one in three adults will be 65-plus by 2033. The European Forum Against Blindness reports that 28% of seniors suffer moderate-to-severe dry eye. Germany and France now reimburse prescription cyclosporine and lifitegrast for documented Sjögren’s cases, shortening diagnosis-to-treatment time and enlarging the treatable population.

Regulatory Streamlining for Devices

EU MDR 2022 re-classified intranasal neuro-stimulators and thermal pulsation systems as Class IIa, trimming approval timelines by 35%. Three new meibomian-gland devices launched in Spain and Italy during 2024, while EMA guidance encourages preservative-free multidose formulations. Faster CE-mark certification lowers entry costs for SMEs and accelerates patient access to non-drug relief.

Digital Eye Strain and Workplace Policies

Eurofound finds 36% of EU workers spend ≥7 hours daily on screens, up from 24% in 2019. The European Agency for Safety and Health at Work 2024 directive recommends blink-rate training and tear subsidies for computer vision syndrome. Major tech campuses in Ireland and the Netherlands now offer pre-tax reimbursement for prescription dry-eye therapies, converting ergonomic policy into measurable demand.

Request a free sample copy of the report: https://www.imarcgroup.com/Europe-Dry-Eye-Syndrome-Market/requestsample

Europe Dry Eye Syndrome Market Segmentation

Analysis by Disease Type

• Evaporative Dry Eye Syndrome
• Aqueous Dry Eye Syndrome

Analysis by Drug Type

• Anti-inflammatory Drugs
• Lubricant Eye Drops
• Autologous Serum Eye Drops

Analysis by Product

• Liquid Drops
• Gel
• Liquid Wipes
• Eye Ointment
• Others

Analysis by Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Analysis by Country

• Germany
• France
• United Kingdom
• Italy
• Spain
• Others

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Request Customization: https://www.imarcgroup.com/request?type=report&id=4916&flag=E

Europe Dry Eye Syndrome Market News

• European Commission added preservative-free ciclosporin to the 2025 essential medicines list, triggering price talks in Belgium and Austria.
• Spanish hospital network prescribes intranasal neuro-stimulator under national tariff, cutting symptom scores 40% in eight weeks.
• France approves single-dose hyaluronic-acid/trehalose combo for severe evaporative dry eye, rolling out to 1,200 rural pharmacies.
• Italy’s Lombardy region launches blink-reminder app linked to prescription refills, boosting lubricant adherence among office workers.

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.